• Title of article

    Autophagy Suppresses Tumorigenesis through Elimination of p62

  • Author/Authors

    Robin Mathew، نويسنده , , Cristina M. Karp، نويسنده , , Brian Beaudoin، نويسنده , , Nhan Vuong، نويسنده , , Guanghua Chen، نويسنده , , Hsin-Yi Chen، نويسنده , , Kevin Bray، نويسنده , , Anupama Reddy، نويسنده , , Gyan Bhanot، نويسنده , , Celine Gelinas، نويسنده , , Robert S. DiPaola، نويسنده , , Vassiliki Karantza-Wadsworth، نويسنده , , Eileen White، نويسنده ,

  • Issue Information
    هفته نامه با شماره پیاپی سال 2009
  • Pages
    14
  • From page
    1062
  • To page
    1075
  • Abstract
    Allelic loss of the essential autophagy gene beclin1 occurs in human cancers and renders mice tumor-prone suggesting that autophagy is a tumor-suppression mechanism. While tumor cells utilize autophagy to survive metabolic stress, autophagy also mitigates the resulting cellular damage that may limit tumorigenesis. In response to stress, autophagy-defective tumor cells preferentially accumulated p62/SQSTM1 (p62), endoplasmic reticulum (ER) chaperones, damaged mitochondria, reactive oxygen species (ROS), and genome damage. Moreover, suppressing ROS or p62 accumulation prevented damage resulting from autophagy defects indicating that failure to regulate p62 caused oxidative stress. Importantly, sustained p62 expression resulting from autophagy defects was sufficient to alter NF-κB regulation and gene expression and to promote tumorigenesis. Thus, defective autophagy is a mechanism for p62 upregulation commonly observed in human tumors that contributes directly to tumorigenesis likely by perturbing the signal transduction adaptor function of p62-controlling pathways critical for oncogenesis.
  • Journal title
    CELL
  • Serial Year
    2009
  • Journal title
    CELL
  • Record number

    1019790